Literature DB >> 26034157

Evaluation of the Satisfaction with Appearance Scale and Its Short Form in Systemic Sclerosis: Analysis from the UCLA Scleroderma Quality of Life Study.

Sarah D Mills1, Rina S Fox1, Erin L Merz1, Philip J Clements1, Suzanne Kafaja1, Vanessa L Malcarne2, Daniel E Furst1, Dinesh Khanna1.   

Abstract

OBJECTIVE: Changes in appearance are common in patients with systemic sclerosis (SSc) and can significantly affect well-being. The Satisfaction with Appearance Scale (SWAP) measures body image dissatisfaction in persons with visible disfigurement; the Brief-Satisfaction with Appearance Scale (Brief-SWAP) is its short form. The present study evaluated the reliability and validity of SWAP and Brief-SWAP scores in SSc.
METHODS: A sample of 207 patients with SSc participating in the University of California, Los Angeles Scleroderma Quality of Life Study completed the SWAP. Brief-SWAP scores were derived from the SWAP. The structural validity of both measures was investigated using confirmatory factor analysis. Internal consistency reliability of total and subscale scores was assessed with Cronbach's alpha coefficients. Convergent and divergent validity was evaluated using the Center for Epidemiological Studies Depression Scale, the Health Assessment Questionnaire-Disability Index, and the Medical Outcomes Study Short Form-36 questionnaire.
RESULTS: SWAP and Brief-SWAP total scores were highly correlated (r = 0.97). The 4-factor structure of the SWAP fit well descriptively; the 2-factor structure of the Brief-SWAP fit well descriptively and statistically. Internal consistencies for total and subscale scores were good, and results supported convergent and divergent validity.
CONCLUSION: Both versions are suitable for use in patients with SSc. The Brief-SWAP is most efficient; the full SWAP yields additional subscales that may be informative in understanding body image issues in patients with SSc.

Entities:  

Keywords:  QUALITY OF LIFE; SCLERODERMA; SYSTEMIC SCLEROSIS

Mesh:

Year:  2015        PMID: 26034157      PMCID: PMC4809411          DOI: 10.3899/jrheum.141482

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

Review 1.  Psychological health and well-being in systemic sclerosis: State of the science and consensus research agenda.

Authors:  Brett D Thombs; Wim van Lankveld; Marielle Bassel; Murray Baron; Robert Buzza; Shirley Haslam; Jennifer A Haythornthwaite; Marie Hudson; Lisa R Jewett; Ruby Knafo; Linda Kwakkenbos; Vanessa L Malcarne; Katherine Milette; Sarosh J Motivala; Evan G Newton; Warren R Nielson; Marion Pacy; Ilya Razykov; Orit Schieir; Suzanne Taillefer; Maureen Worron-Sauve
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-08       Impact factor: 4.794

2.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

3.  Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function.

Authors:  Lisa M Benrud-Larson; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley; Jennifer A Haythornthwaite
Journal:  Health Psychol       Date:  2003-03       Impact factor: 4.267

4.  The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales.

Authors:  J F Fries; P W Spitz; D Y Young
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

5.  Development and validation of the brief-satisfaction with appearance scale for systemic sclerosis.

Authors:  Lisa R Jewett; Marie Hudson; Jennifer A Haythornthwaite; Leslie Heinberg; Fredrick M Wigley; Murray Baron; Brett D Thombs
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-07-27       Impact factor: 4.794

6.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).

Authors:  E M Andresen; J A Malmgren; W B Carter; D L Patrick
Journal:  Am J Prev Med       Date:  1994 Mar-Apr       Impact factor: 5.043

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

Authors:  P J Clements; P A Lachenbruch; J R Seibold; B Zee; V D Steen; P Brennan; A J Silman; N Allegar; J Varga; M Massa
Journal:  J Rheumatol       Date:  1993-11       Impact factor: 4.666

Review 9.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

10.  Sociodemographic and disease correlates of body image distress among patients with systemic sclerosis.

Authors:  Lisa R Jewett; Marie Hudson; Vanessa L Malcarne; Murray Baron; Brett D Thombs
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

View more
  6 in total

1.  Validation of the Social Interaction Anxiety Scale in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort study.

Authors:  Shadi Gholizadeh; Linda Kwakkenbos; Marie-Eve Carrier; Sarah D Mills; Rina S Fox; Lisa R Jewett; Karen Gottesman; Scott Roesch; Brett D Thombs; Vanessa L Malcarne
Journal:  J Scleroderma Relat Disord       Date:  2017-10-24

Review 2.  Patient-reported outcome instruments in clinical trials of systemic sclerosis.

Authors:  John D Pauling; Joana Caetano; Corrado Campochiaro; Giacomo De Luca; Ana Maria Gheorghiu; Maria Grazia Lazzaroni; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2019-11-25

3.  Validity and correlates of the Brief Satisfaction With Appearance Scale for patients with limited and diffuse systemic sclerosis: Analysis from the University of California, Los Angeles Scleroderma Quality of Life Study.

Authors:  Rina S Fox; Sarah D Mills; Shadi Gholizadeh; Erin L Merz; Scott C Roesch; Philip J Clements; Suzanne Kafaja; Dinesh Khanna; Daniel E Furst; Vanessa L Malcarne
Journal:  J Scleroderma Relat Disord       Date:  2019-12-22

4.  Reliability, validity, and responsiveness to change of the Patient-Reported Outcomes Measurement Information System self-efficacy for managing chronic conditions measure in systemic sclerosis.

Authors:  Susan L Murphy; Veronica J Berrocal; Janet L Poole; Dinesh Khanna
Journal:  J Scleroderma Relat Disord       Date:  2021-10-20

5.  Factor structure and convergent validity of the Derriford Appearance Scale-24 using standard scoring versus treating 'not applicable' responses as missing data: a Scleroderma Patient-centered Intervention Network (SPIN) cohort study.

Authors:  Erin L Merz; Linda Kwakkenbos; Marie-Eve Carrier; Shadi Gholizadeh; Sarah D Mills; Rina S Fox; Lisa R Jewett; Heidi Williamson; Diana Harcourt; Shervin Assassi; Daniel E Furst; Karen Gottesman; Maureen D Mayes; Tim P Moss; Brett D Thombs; Vanessa L Malcarne
Journal:  BMJ Open       Date:  2018-03-06       Impact factor: 2.692

Review 6.  State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases.

Authors:  Leopoldo Trieste; Sara Cannizzo; Ilaria Palla; Isotta Triulzi; Giuseppe Turchetti
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.